3 top medical experts on Lethal Neonatal Carnitine Palmitoyltransferase II Deficiency across 0 countries and 1 U.S. states, including 1 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Lethal Neonatal Carnitine Palmitoyltransferase II Deficiency: The neonatal form of carnitine palmitoyltransferase II (CPT II) deficiency (see this term), an inherited disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA), is the lethal form of the disease which presents with multisystem failure.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Synonyms: Lethal Neonatal CPT II Deficiency,  Lethal Neonatal CPT2 Deficiency,  Antenatal Carnitine Palmitoyltransferase II Deficiency,  Neonatal Carnitine Palmitoyltransferase II Deficiency


  

        

                    


    Computing Expert Listing ...